The study shows that when clinical recommendations are followed, genomic sequencing panels increase the efficacy of treatments and patient survival
Read moreUn equipo de investigadores del Centro Médico Universitario de Utrecht, el Instituto de Oncología Vall d’Hebron y la Fundación Médica Hartwig ha analizado el genoma completo de los 23 tipos de c...
Read moreDeveloped by CNIO and the University of Vigo, the PanDrugs2 programme analyses alterations in tumour genes, relates them to existing available drugs, and reports on the most suitable ones
Read moreThe phase III randomized multi-center CAPItello-291 assessed the efficacy and safety of novel AKT inhibitor capivasertib plus fulvestrant in patients with advanced HR+/ HER2- breast cancer who had pro...
Read moreThe study, published in the journal Nature Communications, opens the door to the development of effective drug candidates that fully harness the therapeutic potential of Siglec-15. This knowledge will...
Read moreHan demostrado en un estudio como el gen MAPK11 es clave para entender los fenómenos de radio resistencia en las células tumorales al controlar el proceso de senescencia, una de las respuestas clave...
Read moreNuage Therapeutics (“Nuage”) announces today the successful closing of a €12 million Seed financing to support the development of its lead program and validate its pioneering drug discovery plat...
Read moreTagworks Pharmaceuticals BV (“Tagworks”), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financin...
Read moreOneChain Immunotherapeutics (OCI), a clinical stage biotech company focused on the development of CAR-T candidates for the treatment of oncological diseases, today announced the closing of a €6.7 mi...
Read moreIt has been determined that a specific type of protein, IκBα, is a prognostic marker in one of the types of cancer with the highest mortality, diffuse glioma. Specifically, in the case of patients w...
Read moreCiQUS researchers will participate in CAR T-REX, a new project funded with €2.7M by the European Innovation Council (EIC) to develop novel, scalable CAR T cell therapies with increased efficacy for ...
Read moreEl estudio experimental ha demostrado que las inmunoterapias que se aplican actualmente en los pacientes tienen un efecto parcial en este nuevo modelo animal. Sin embargo, su eficacia aumenta con comb...
Read more